Literature DB >> 8574212

Improving the quality of antimicrobial drug use can result in cost containment.

I C Gyssens1, B J Kullberg.   

Abstract

Antibiotic policies are implemented to optimize patient care, to limit antimicrobial resistance and to reduce costs. Before improving the use of antimicrobial drugs by monitoring, it is of primary importance to conduct a general utilization review to document problem areas within the hospital and to evaluate quality and costs. Subsequently, limited targets for an intervention can be defined. For the evaluation of quality, established criteria can be used to classify prescriptions into categories of appropriate use. Several classification systems are described in the literature. We have developed a classification method which allows evaluation of each relevant parameter associated with antimicrobial drug use and global (true) cost calculation. Data are processed in a computer program for Apple or Windows. Surgical prophylaxis is a target of choice to analyse at a hospital pharmacy level. Important cost savings can be obtained by implementing well-accepted standards of good antimicrobial prophylaxis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8574212     DOI: 10.1007/bf01879711

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  17 in total

1.  Cost of hospital antimicrobial chemotherapy. A method for global cost calculation.

Authors:  I C Gyssens; C A Lennards; Y A Hekster; J W Van der Meer
Journal:  Pharm Weekbl Sci       Date:  1991-12-13

2.  Computer modelling antibiotic therapy costs. Impact of therapeutic range.

Authors:  H E Gladen
Journal:  Drugs       Date:  1988       Impact factor: 9.546

3.  Hospital usage of parenteral antimicrobial agents: a gradated utilization review and cost containment program.

Authors:  L L Pelletier
Journal:  Infect Control       Date:  1985-06

4.  Survey of antibiotic prescribing in a district general hospital. I. Pattern of use.

Authors:  F Moss; M W McNicol; D A McSwiggan; D L Miller
Journal:  Lancet       Date:  1981-08-15       Impact factor: 79.321

5.  The effect of an educational program upon hospital antibiotic use.

Authors:  S R Jones; J Pannell; J Barks; Y A Yanchick; T Bratton; R Browne; E McRee; J W Smith
Journal:  Am J Med Sci       Date:  1977 Jan-Feb       Impact factor: 2.378

6.  A study of antimicrobial misuse in a university hospital.

Authors:  D G Maki; A A Schuna
Journal:  Am J Med Sci       Date:  1978 May-Jun       Impact factor: 2.378

Review 7.  Quality standard for antimicrobial prophylaxis in surgical procedures. The Infectious Diseases Society of America.

Authors:  E P Dellinger; P A Gross; T L Barrett; P J Krause; W J Martone; J E McGowan; R L Sweet; R P Wenzel
Journal:  Infect Control Hosp Epidemiol       Date:  1994-03       Impact factor: 3.254

Review 8.  Strategic antibiotic decision-making at the formulary level.

Authors:  R Quintiliani; C H Nightingale; H M Crowe; B W Cooper; R C Bartlett; G Gousse
Journal:  Rev Infect Dis       Date:  1991 Jul-Aug

9.  The defined daily dose per 100 bed-days as a unit of comparison and a parameter for studying antimicrobial drug use in a university hospital. A retrospective study of the effects of guidelines and audit on antimicrobial drug use.

Authors:  Y A Hekster; T B Vree; R J Goris; J B Boerema
Journal:  J Clin Hosp Pharm       Date:  1982-12

10.  Antimicrobial misuse in patients with positive blood cultures.

Authors:  W C Dunagan; R S Woodward; G Medoff; J L Gray; E Casabar; M D Smith; C A Lawrenz; E Spitznagel
Journal:  Am J Med       Date:  1989-09       Impact factor: 4.965

View more
  3 in total

1.  Application of the ATC/DDD methodology to monitor antibiotic drug use.

Authors:  S Natsch; Y A Hekster; R de Jong; E R Heerdink; R M Herings; J W van der Meer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-01       Impact factor: 3.267

2.  Diagnosing infections: a qualitative view on prescription decisions in general practice over time.

Authors:  Ingunn Björnsdóttir; Karl G Kristinsson; Ebba Holme Hansen
Journal:  Pharm World Sci       Date:  2010-10-08

3.  Assessing antibacterial pharmacoeconomics in the intensive care unit.

Authors:  M C Birmingham; J M Hassett; J J Schentag; J A Paladino
Journal:  Pharmacoeconomics       Date:  1997-12       Impact factor: 4.981

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.